Iopentol (Imagopaque® 300) compared with iopromide (Ultravist® 300) in abdominal CT A multi-centre monitoring trial assessing adverse events and diagnostic …

JL Encina, L Marti-Bonmati, CL Ronchera-Oms… - European …, 1997 - Springer
Objectives: Iopentol (Nycomed Imaging AS, Oslo, Norway) and iopromide (Schering AG,
Berlin, Germany) are low-osmolar, non-ionic, iodinated contrast media (CM) used in …

Oral administration of iopentol (Imagopaque® 300 mg I/ml) compared with amidotrizoate (Peritrast® 300 mg I/ml), both diluted to 2%(v/v), in imaging of the …

JM Friedrich, K Skinningsrud, C Welter, H Eide… - European …, 1997 - Springer
The aim of the trial was to evaluate and compare the safety and efficacy of iopentol
(Imagopaque®, Nycomed Imaging AS, Oslo, Norway) and amidotrizoate (Peritrast®, Köhler …

Double-blind randomized study comparing ioversol 300 versus iopromide 300 abdominal computed tomography (CT scanner)

HM Hoogewoud, AC Neiss, B Woessmer - Annales de Radiologie, 1992 - europepmc.org
The authors compared ioversol 300 and iopromide 300 (ioversol 41 patients, iopromide 38
patients) in a randomized double blind study conducted on 79 patients undergoing …

Iopentol (Imagopaque® 350) compared with diatrizoate (Urografin® 370) in cerebral CT A clinical trial assessing immediate and late (7 days) adverse events and …

A Valentine, JÅ Jakobsen, AJ Klaveness - European Radiology, 1997 - Springer
The non-ionic contrast medium iopentol (Imagopaque®, Nycomed Imaging AS, Oslo,
Norway) 350 mg I/ml was compared for safety and efficacy with the ionic contrast medium …

Iomeprol versus iopamidol in contrast-enhanced computed tomography of thoracic and abdominal organs

AL Valentini, T Tartaglione, L Monti… - European journal of …, 1994 - Elsevier
The aim of this double-blind, parallel-group study was to compare the safety, tolerance, and
efficacy of iomeprol-350 (350 mgI/ml), iomeprol-400 (400 mgI/ml) and iopamidol-370 (370 …

Enhancement and safety of iomeprol-400 and iodixanol-320 in patients undergoing abdominal multidetector CT

L Romano, L Grazioli, L Bonomo, JR Xu… - The British Journal of …, 2009 - birpublications.org
The purpose of this study was to compare iomeprol-400 and iodixanol-320 for contrast
enhancement and safety in patients undergoing liver multidetector CT (MDCT). 183 patients …

Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial

FL Weiland, L Marti-Bonmati, L Lim… - Acta …, 2014 - journals.sagepub.com
Background Previous clinical studies have shown that iso-osmolar iodixanol (Visipaque®)
causes less patient discomfort than low-osmolar contrast media (LOCM) when administered …

A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography

DV Sahani, G Soulez, KM Chen, L Lepanto… - Investigative …, 2007 - journals.lww.com
Objectives: To prospectively compare the effects on heart rate (HR) and contrast
enhancement efficacy of iopamidol-370 and iodixanol-320 in contrast-enhanced …

Iobitridol 300 compared to iopromide 300--a double-blind randomized phase-III study of clinical tolerance in total body CT.

HM Hoogewoud, B Woessmer - Acta radiologica. Supplementum, 1996 - europepmc.org
PURPOSE, MATERIAL AND METHODS: The clinical safety of iobitriodol 300 mg I/ml and
iopromide 300 mg I/ml were compared in a randomized double blind phase-III study …

Iopentol compared with iohexol for abdominal CT

A Kolbenstvedt, F Aspestrand, H Knudsen… - Iopentol. Clinical trials …, 1990 - inis.iaea.org
[en] In a prospective randomized, double-blind, parallel study the new contrast medium (CM)
iopentol (Nycomed AS, Oslo, Norway, was compared with iohexol in 63 adult patients …